Key result
This review highlights the pathomechanisms of HPV-related cardiovascular disease and the need for novel biomarkers to detect early atherosclerotic changes for personalized risk prediction.
Why the study?
Women with genital HPV infection have an increased incidence of CVD, but the pathomechanisms are not fully understood and personalised prediction of cardiovascular events using novel biomarkers is missing.
Design
Review
Authors
Loading...
Genital HPV may flag elevated CVD risk in women; leaves open causal mechanisms and prospective validation.
This review highlights the need for novel biomarkers to detect early atherosclerotic changes for personalized cardiovascular risk prediction in women with HPV infection and cervical cancer.
Tonhajzerová et al. (2019) conducted a review in Cervical cancer, Human Papillomavirus (HPV) infection, and Cardiovascular Disease. Human papillomavirus (HPV) infection and novel biomarkers was evaluated. This review highlights the pathomechanisms of HPV-related cardiovascular disease and the need for novel biomarkers to detect early atherosclerotic changes for personalized risk prediction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: